Kalyani Vemuri

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression.

Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression.

Journal: Neuro-oncology advances
Published: February 11, 2025

Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX® Theranostic Nanoparticles.

Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX® Theranostic Nanoparticles.

Journal: Cancers
Published: October 30, 2024

AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis.

AAV-mouse DNase I sustains long-term DNase I expression in vivo and suppresses breast cancer metastasis.

Journal: FASEB bioAdvances
Published: July 17, 2024

Author Correction: A method for Boolean analysis of protein interactions at a molecular level.

Author Correction: A method for Boolean analysis of protein interactions at a molecular level.

Journal: Nature communications
Published: September 06, 2023

CD93 maintains endothelial barrier function and limits metastatic dissemination.

CD93 maintains endothelial barrier function and limits metastatic dissemination.

Journal: JCI insight
Published: February 17, 2023

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma.

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma.

Journal: Cancer cell
Published: June 10, 2022

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.

ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.

Journal: Neuro-oncology
Published: August 04, 2021

A method for Boolean analysis of protein interactions at a molecular level.

A method for Boolean analysis of protein interactions at a molecular level.

Journal: Nature communications
Published: July 01, 2021

CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.

CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.

Journal: The Journal of clinical investigation
Published: September 12, 2017
Showing 1-9 of 9

Last Updated: 09/26/2026